← Open Payments lookup

MARK HUTTO: Open Payments

NPI 1699844159 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,818 in 13 payments from 8 companies in 2025. Trend: 2023 $502 · 2024 $306 · 2025 $4,818

Debt forgiveness: $4,575Food & beverage: $243
CompanyPaymentsAmount
Neuronetics, Inc.1$4,575
E.R. Squibb & Sons, L.L.C.4$85
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$30
Lundbeck LLC1$30
Neurocrine BioSciences, Inc.2$29
Otsuka America Pharmaceutical, Inc.1$29
Janssen Pharmaceuticals, Inc1$23
Teva Pharmaceuticals USA, Inc.1$17

Products named: NEUROSTAR TMS THERAPY SYSTEM, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, INGREZZA, INVEGA SUSTENNA, UZEDY.

Industry payments across GA — which companies pay providers there.